Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Tretinoin may be effective for treating Fox-Fordyce disease.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

FOXN1 gene variants cause low T cells and immune issues from birth.

Tofacitinib treatment is used for teenagers with alopecia areata.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Trichoscopy helped diagnose and treat a child's fungal scalp infection by spotting specific hair shapes.

Cathepsin L deficiency causes large, abnormal cell structures and health issues in mice.

A new compound was effective for imaging prostate cancer in rats.

Modified β-catenin causes different effects in hair and skin cells, leading to cysts or tumors.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

NFATc1 is crucial for keeping hair follicle stem cells inactive.

The Hair Cell Analysis Toolbox automates and improves the analysis of cochlear hair cells using machine learning.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

CCCA mainly affects Black women and is linked to high-tension hairstyles, heating tools, chemical relaxants, and genetics.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

CCCA can affect both genders and all ages, and it has a genetic component.

Excessive iodine from a cystic fibrosis supplement can cause hypothyroidism.

TB and BCC tumors show similar follicular differentiation patterns.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Deleting Crif1 in mouse skin disrupts skin balance and hair growth.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.